Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$533.8K
8 trades · 4 insiders
Net · 90d
$-533.8K
Insiders on file
24
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Moore Stephen Michael | SVP and Chief Legal Officer | 28 | $0 | $171.7K | 2026-09-18 |
| Chen Richard | President and CMO | 120 | $0 | $9.15M | 2026-09-18 |
| Hall Christopher M | President and CEO | 24 | $0 | $4.59M | 2026-09-18 |
| Tachibana Aaron | Chief Financial Officer | 81 | $0 | $4.02M | 2026-09-18 |
| Bloom Olivia Kyusuk | Director | 9 | $0 | $0 | 2026-05-12 |
| Shoff Lonnie | Director | 7 | $0 | $0 | 2026-05-12 |
| MYERS WOODROW A JR | Director | 12 | $16.7K | $0 | 2026-05-12 |
| EASTHAM KARIN | Director | 12 | $0 | $0 | 2026-05-12 |
| WIDDER KENNETH J | Director | 5 | $0 | $0 | 2026-05-12 |
| BOWMAN A BLAINE | Director | 10 | $0 | $0 | 2026-05-12 |
| Tempus AI, Inc. | 10% Owner | 17 | $20.48M | $0 | 2025-12-22 |
| Colowick Alan | Director | 6 | $0 | $0 | 2023-05-17 |
| West John Stephen | President and CEO | 57 | $0 | $10.76M | 2022-12-14 |
| LUDLUM KEN | Director | 10 | $1.19M | $403.4K | 2022-05-17 |
| Nieh Peter | Other | 3 | $3.10M | $0 | 2022-03-03 |
| MacQuitty Jonathan | Director | 3 | $0 | $0 | 2021-05-14 |
| Abingworth LLP | Other | 14 | $0 | $38.49M | 2020-10-20 |
| Lightspeed Ultimate General Partner Select IV, L.L.C. | Other | 1 | $25.00M | $0 | 2020-08-14 |
| Janmohamed Arif | Other | 2 | $6.33M | $0 | 2020-06-02 |
| BALTHROP PATRICK J | Director | 1 | $0 | $0 | 2020-05-15 |
| RICCI PAUL | Director | 3 | $680.0K | $0 | 2020-05-15 |
| Musil Clinton | Chief Business Officer | 2 | $0 | $0 | 2020-03-16 |
| Liew Jeremy | 10% Owner | 6 | $0 | $0 | 2019-06-24 |
| FEIBER JONATHAN D | 10% Owner | 14 | $0 | $0 | 2019-06-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO | S Sale | 2026-09-18 | 2026-09-22 | 2,931 | $16.22 | $47.5K | 195,902 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | S Sale | 2026-09-18 | 2026-09-22 | 7,459 | $16.22 | $121.0K | 228,527 | SEC↗ |
| Chen Richard | President and CMO | S Sale | 2026-09-18 | 2026-09-22 | 3,998 | $16.22 | $64.8K | 169,882 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2026-09-18 | 2026-09-22 | 2,068 | $16.22 | $33.5K | 90,257 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-09-18 | 2026-09-22 | 2,931 | $16.22 | $47.5K | 195,902 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2026-09-18 | 2026-09-22 | 2,068 | $16.22 | $33.5K | 90,257 | SEC↗ |
| Hall Christopher M | Chief Executive Officer, Dir | S Sale | 2026-09-18 | 2026-09-22 | 7,459 | $16.22 | $121.0K | 228,527 | SEC↗ |
| Chen Richard | President and CMO | S Sale | 2026-09-18 | 2026-09-22 | 3,998 | $16.22 | $64.8K | 169,882 | SEC↗ |
| Chen Richard | President and CMO | M Exercise deriv | 2026-07-15 | 2026-07-15 | 100,000 | — | $0 | 0 | SEC↗ |
| Chen Richard | President and CMO | M Exercise | 2026-07-15 | 2026-07-15 | 100,000 | $2.44 | $244.0K | 273,880 | SEC↗ |
| Chen Richard | President and CMO | S Sale | 2026-07-15 | 2026-07-15 | 100,000 | $15.15 | $1.51M | 173,880 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise deriv | 2026-07-09 | 2026-07-09 | 66,667 | — | $0 | 133,333 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise deriv | 2026-07-09 | 2026-07-09 | 33,333 | — | $0 | 0 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | S Sale | 2026-07-09 | 2026-07-09 | 100,000 | $15.08 | $1.51M | 235,986 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise | 2026-07-09 | 2026-07-09 | 100,000 | $1.61 | $161.0K | 335,986 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-06-29 | 2026-06-29 | 4,982 | — | $0 | 2,489 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-06-29 | 2026-06-29 | 4,982 | $5.32 | $26.5K | 203,815 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-06-29 | 2026-06-29 | 4,982 | $14.00 | $69.7K | 198,833 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise deriv | 2026-06-26 | 2026-06-26 | 100,000 | — | $0 | 200,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-06-26 | 2026-06-26 | 28,832 | — | $0 | 0 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-06-26 | 2026-06-26 | 22,419 | — | $0 | 7,471 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | S Sale | 2026-06-26 | 2026-06-26 | 100,000 | $13.15 | $1.31M | 235,986 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise | 2026-06-26 | 2026-06-26 | 100,000 | $1.61 | $161.0K | 335,986 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-06-26 | 2026-06-26 | 51,251 | $13.18 | $675.5K | 198,833 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-06-26 | 2026-06-26 | 28,832 | $9.16 | $264.1K | 227,665 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-06-26 | 2026-06-26 | 22,419 | $5.32 | $119.3K | 250,084 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-06-04 | 2026-06-05 | 40,000 | — | $0 | 28,832 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-06-04 | 2026-06-05 | 40,000 | $9.16 | $366.4K | 238,833 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-06-04 | 2026-06-05 | 40,000 | $12.01 | $480.4K | 198,833 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-05-29 | 2026-05-29 | 38,799 | — | $0 | 68,832 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise deriv | 2026-05-29 | 2026-05-29 | 80,091 | — | $0 | 300,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-05-29 | 2026-05-29 | 38,799 | $11.58 | $449.3K | 198,833 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-05-29 | 2026-05-29 | 38,799 | $9.16 | $355.4K | 237,632 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise | 2026-05-29 | 2026-05-29 | 80,091 | $1.61 | $128.9K | 316,077 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | S Sale | 2026-05-29 | 2026-05-29 | 80,091 | $11.02 | $882.6K | 235,986 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise deriv | 2026-05-28 | 2026-05-29 | 19,909 | — | $0 | 380,091 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | S Sale | 2026-05-28 | 2026-05-29 | 19,909 | $11.02 | $219.4K | 235,986 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | M Exercise | 2026-05-28 | 2026-05-29 | 19,909 | $1.61 | $32.1K | 255,895 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Shoff Lonnie | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| WIDDER KENNETH J | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| EASTHAM KARIN | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 32,366 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 27,265 | SEC↗ |
| Shoff Lonnie | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 37,190 | SEC↗ |
| WIDDER KENNETH J | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 19,756 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2026-05-12 | 2026-05-14 | 6,250 | — | $0 | 22,366 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2026-05-12 | 2026-06-11 | 6,250 | — | $0 | 19,756 | SEC↗ |
| Chen Richard | President and CMO | A Award deriv | 2026-03-15 | 2026-03-17 | 281,250 | — | $0 | 281,250 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 525,000 | — | $0 | 525,000 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | A Award deriv | 2026-03-15 | 2026-03-17 | 168,750 | — | $0 | 168,750 | SEC↗ |
| Tachibana Aaron | CFO AND COO | A Award deriv | 2026-03-15 | 2026-03-17 | 206,250 | — | $0 | 206,250 | SEC↗ |
| Chen Richard | President and CMO | A Award | 2026-03-15 | 2026-03-17 | 46,875 | — | $0 | 173,880 | SEC↗ |
| Hall Christopher M | Chief Executive Officer | A Award | 2026-03-15 | 2026-03-17 | 87,500 | — | $0 | 235,986 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | A Award | 2026-03-15 | 2026-03-17 | 28,125 | — | $0 | 92,325 | SEC↗ |
| Tachibana Aaron | CFO AND COO | A Award | 2026-03-15 | 2026-03-17 | 34,375 | — | $0 | 198,833 | SEC↗ |
| Hall Christopher M | PRESIDENT AND CEO | A Award deriv | 2026-02-23 | 2026-02-25 | 33,333 | — | $0 | 33,333 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | A Award deriv | 2026-02-23 | 2026-02-25 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | A Award deriv | 2026-02-23 | 2026-02-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | A Award deriv | 2026-02-23 | 2026-02-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2026-01-22 | 2026-01-23 | 1,201 | — | $0 | 107,631 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2026-01-22 | 2026-01-23 | 1,201 | $9.16 | $11.0K | 165,659 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2026-01-22 | 2026-01-23 | 1,201 | $11.50 | $13.8K | 164,458 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-12-22 | 2026-02-13 | 28,000 | $8.93 | $250.0K | 13,039,067 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-12-19 | 2026-02-13 | 29,641 | $8.39 | $248.7K | 13,011,067 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-12-18 | 2026-02-13 | 31,430 | $7.91 | $248.6K | 12,981,426 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-12-17 | 2026-02-13 | 31,650 | $7.86 | $248.8K | 12,949,996 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-25 | 2026-02-13 | 9,712 | $10.08 | $97.9K | 12,904,458 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-25 | 2026-02-13 | 13,888 | $11.00 | $152.8K | 12,918,346 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise deriv | 2025-11-25 | 2025-11-28 | 103,668 | — | $0 | 108,832 | SEC↗ |
| Tachibana Aaron | CFO AND COO | M Exercise | 2025-11-25 | 2025-11-28 | 103,668 | $9.16 | $949.6K | 268,126 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2025-11-25 | 2025-11-28 | 103,668 | $10.78 | $1.12M | 164,458 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-24 | 2026-02-13 | 25,225 | $9.87 | $249.0K | 12,894,746 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-21 | 2026-02-13 | 16,599 | $9.74 | $161.7K | 12,869,521 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-21 | 2026-02-13 | 9,900 | $8.84 | $87.5K | 12,852,922 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-20 | 2026-02-13 | 28,827 | $8.63 | $248.8K | 12,843,022 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-19 | 2026-02-13 | 30,645 | $8.12 | $248.8K | 12,814,195 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2025-11-18 | 2026-02-13 | 64,750 | $7.67 | $496.6K | 12,783,550 | SEC↗ |
| Hall Christopher M | PRESIDENT AND CEO | S Sale | 2025-11-03 | 2025-11-05 | 29,612 | $8.99 | $266.2K | 148,486 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2025-07-28 | 2025-07-30 | 641 | $6.57 | $4.2K | 164,458 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2025-07-28 | 2025-07-30 | 452 | $6.57 | $3.0K | 124,505 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EASTHAM KARIN | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| WIDDER KENNETH J | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Shoff Lonnie | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award deriv | 2025-05-16 | 2025-05-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2025-05-16 | 2025-05-20 | 910 | $4.95 | $4.5K | 124,957 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2025-05-16 | 2025-05-20 | 1,675 | $4.95 | $8.3K | 64,200 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2025-05-16 | 2025-05-20 | 1,291 | $4.95 | $6.4K | 165,099 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | A Award deriv | 2025-03-15 | 2025-03-18 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Hall Christopher M | PRESIDENT AND CEO | A Award deriv | 2025-03-15 | 2025-03-18 | 680,000 | — | $0 | 680,000 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | A Award deriv | 2025-03-15 | 2025-03-18 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | A Award deriv | 2025-03-15 | 2025-03-18 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2025-01-28 | 2025-01-30 | 519 | $5.79 | $3.0K | 123,367 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2025-01-28 | 2025-01-30 | 708 | $5.79 | $4.1K | 166,390 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-12-16 | 2024-12-18 | 6,865 | $3.82 | $26.2K | 167,098 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2024-12-16 | 2024-12-18 | 1,513 | $3.82 | $5.8K | 65,875 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-12-16 | 2024-12-18 | 4,834 | $3.82 | $18.5K | 123,886 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-11-18 | 2024-11-20 | 921 | $3.79 | $3.5K | 128,720 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2024-11-18 | 2024-11-20 | 1,693 | $3.79 | $6.4K | 67,388 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-11-18 | 2024-11-20 | 1,307 | $3.79 | $5.0K | 173,963 | SEC↗ |
| Hall Christopher M | PRESIDENT AND CEO | S Sale | 2024-11-01 | 2024-11-05 | 26,443 | $5.38 | $142.3K | 178,098 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | X Exercise deriv | 2024-08-16 | 2024-08-20 | 4,609,400 | — | $0 | 0 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | X Exercise deriv | 2024-08-16 | 2024-08-20 | 4,609,400 | — | $0 | 0 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | X Exercise | 2024-08-16 | 2024-08-20 | 4,609,400 | $1.50 | $6.91M | 4,609,400 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | X Exercise | 2024-08-16 | 2024-08-20 | 4,609,400 | $2.50 | $11.52M | 9,218,800 | SEC↗ |
| Tempus AI, Inc. | 10% Owner | P Buy | 2024-08-16 | 2024-08-20 | 3,500,000 | $5.07 | $17.75M | 12,718,800 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-07-30 | 2024-08-01 | 742 | $2.97 | $2.2K | 175,270 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-07-30 | 2024-08-01 | 524 | $2.97 | $1.6K | 127,227 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2024-06-17 | 2024-06-20 | 1,585 | $1.29 | $2.0K | 69,081 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-06-17 | 2024-06-20 | 7,176 | $1.29 | $9.3K | 176,012 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-06-17 | 2024-06-20 | 5,055 | $1.29 | $6.5K | 127,751 | SEC↗ |
| WIDDER KENNETH J | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EASTHAM KARIN | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Shoff Lonnie | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award deriv | 2024-05-17 | 2024-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2024-05-17 | 2024-05-21 | 1,731 | $1.38 | $2.4K | 70,666 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-05-17 | 2024-05-21 | 1,333 | $1.38 | $1.8K | 183,188 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-05-17 | 2024-05-21 | 940 | $1.38 | $1.3K | 132,806 | SEC↗ |
| Moore Stephen Michael | SVP and Chief Legal Officer | S Sale | 2024-04-30 | 2024-05-02 | 4,523 | $1.37 | $6.2K | 72,397 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | A Award deriv | 2024-03-15 | 2024-03-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Moore Stephen Michael | GENERAL COUNSEL | A Award deriv | 2024-03-15 | 2024-03-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Tachibana Aaron | CFO AND COO | A Award deriv | 2024-03-15 | 2024-03-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Hall Christopher M | PRESIDENT AND CEO | A Award deriv | 2024-03-15 | 2024-03-19 | 400,000 | — | $0 | 400,000 | SEC↗ |
| MYERS WOODROW A JR | Director | P Buy | 2024-03-01 | 2024-03-05 | 10,000 | $1.67 | $16.7K | 26,116 | SEC↗ |
| Tachibana Aaron | CFO AND COO | S Sale | 2024-01-29 | 2024-01-31 | 716 | $1.37 | $981 | 184,521 | SEC↗ |
| Chen Richard | CHIEF MEDICAL OFFICER AND EV | S Sale | 2024-01-29 | 2024-01-31 | 526 | $1.37 | $721 | 128,870 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2023-12-15 | 2023-12-19 | 1,476 | $1.47 | $2.2K | 76,920 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-12-15 | 2023-12-19 | 6,747 | $1.47 | $9.9K | 185,237 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-12-15 | 2023-12-19 | 4,708 | $1.47 | $6.9K | 129,396 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2023-11-16 | 2023-11-20 | 1,722 | $1.04 | $1.8K | 78,396 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-11-16 | 2023-11-20 | 940 | $1.04 | $978 | 124,104 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-11-16 | 2023-11-20 | 1,344 | $1.04 | $1.4K | 191,984 | SEC↗ |
| Hall Christopher M | President and CEO | S Sale | 2023-11-01 | 2023-11-03 | 20,459 | $0.93 | $19.0K | 204,541 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-07-31 | 2023-08-02 | 485 | $2.26 | $1.1K | 125,044 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-07-31 | 2023-08-02 | 662 | $2.26 | $1.5K | 193,328 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-06-16 | 2023-06-21 | 6,904 | $2.07 | $14.3K | 193,990 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-06-16 | 2023-06-21 | 4,817 | $2.07 | $10.0K | 125,529 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2023-06-16 | 2023-06-21 | 1,509 | $2.07 | $3.1K | 80,118 | SEC↗ |
| WIDDER KENNETH J | Director | A Award deriv | 2023-06-13 | 2023-06-14 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Colowick Alan | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Shoff Lonnie | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EASTHAM KARIN | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award deriv | 2023-05-17 | 2023-05-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-05-17 | 2023-05-19 | 971 | $1.98 | $1.9K | 130,346 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2023-05-17 | 2023-05-19 | 1,781 | $1.98 | $3.5K | 81,627 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-05-17 | 2023-05-19 | 1,389 | $1.98 | $2.8K | 200,894 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2023-05-02 | 2023-05-04 | 5,102 | $2.29 | $11.7K | 83,408 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | S Sale | 2023-03-17 | 2023-03-21 | 1,314 | $2.83 | $3.7K | 131,317 | SEC↗ |
| Tachibana Aaron | CFO and COO | S Sale | 2023-03-17 | 2023-03-21 | 3,945 | $2.83 | $11.2K | 202,283 | SEC↗ |
| Hall Christopher M | President and CEO | A Award deriv | 2023-03-15 | 2023-03-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Tachibana Aaron | CFO and COO | A Award deriv | 2023-03-15 | 2023-03-17 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Chen Richard | Chief Medical Officer and EV | A Award deriv | 2023-03-15 | 2023-03-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Moore Stephen Michael | General Counsel | A Award deriv | 2023-03-15 | 2023-03-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2023-01-31 | 2023-02-02 | 562 | $2.20 | $1.2K | 132,631 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2023-01-31 | 2023-02-02 | 767 | $2.20 | $1.7K | 206,228 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-12-20 | 2022-12-22 | 1,750 | $1.92 | $3.4K | 133,193 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-12-20 | 2022-12-22 | 3,843 | $1.92 | $7.4K | 206,995 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-12-15 | 2022-12-19 | 7,177 | $2.50 | $17.9K | 134,943 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-12-15 | 2022-12-19 | 7,177 | $2.50 | $17.9K | 210,838 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2022-12-15 | 2022-12-19 | 1,930 | $2.50 | $4.8K | 88,510 | SEC↗ |
| West John Stephen | President and CEO | M Exercise deriv | 2022-12-14 | 2022-12-14 | 10,000 | — | $0 | 239,999 | SEC↗ |
| West John Stephen | President and CEO | M Exercise | 2022-12-14 | 2022-12-14 | 10,000 | $2.44 | $24.4K | 622,444 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-12-02 | 2022-12-06 | 440 | $2.60 | $1.1K | 142,120 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-12-02 | 2022-12-06 | 4,360 | $2.60 | $11.3K | 218,015 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-11-16 | 2022-11-18 | 1,294 | $2.71 | $3.5K | 222,375 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2022-11-16 | 2022-11-18 | 2,045 | $2.71 | $5.5K | 90,440 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-11-16 | 2022-11-18 | 1,295 | $2.71 | $3.5K | 142,560 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-09-20 | 2022-09-22 | 3,474 | $3.48 | $12.1K | 223,669 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-09-20 | 2022-09-22 | 1,581 | $3.48 | $5.5K | 143,855 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-09-02 | 2022-09-08 | 4,168 | $3.33 | $13.9K | 227,143 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-09-02 | 2022-09-08 | 420 | $3.33 | $1.4K | 145,436 | SEC↗ |
| West John Stephen | President and CEO | A Award deriv | 2022-08-15 | 2022-08-17 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | A Award deriv | 2022-08-15 | 2022-08-17 | 29,890 | — | $0 | 29,890 | SEC↗ |
| Chen Richard | Chief Medical Officer | A Award deriv | 2022-08-15 | 2022-08-17 | 29,890 | — | $0 | 29,890 | SEC↗ |
| Moore Stephen Michael | General Counsel | A Award deriv | 2022-08-15 | 2022-08-17 | 28,700 | — | $0 | 28,700 | SEC↗ |
| Moore Stephen Michael | General Counsel | A Award deriv | 2022-08-15 | 2022-09-07 | 28,700 | — | $0 | 28,700 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-08-15 | 2022-08-17 | 230,000 | — | $0 | 612,444 | SEC↗ |
| Moore Stephen Michael | General Counsel | A Award | 2022-08-15 | 2022-08-17 | 18,600 | — | $0 | 92,485 | SEC↗ |
| Moore Stephen Michael | General Counsel | A Award | 2022-08-15 | 2022-09-07 | 18,600 | — | $0 | 92,485 | SEC↗ |
| Shoff Lonnie | Director | A Award deriv | 2022-08-02 | 2022-08-04 | 47,345 | — | $0 | 47,345 | SEC↗ |
| Shoff Lonnie | Director | A Award | 2022-08-02 | 2022-08-04 | 30,940 | — | $0 | 30,940 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-07-28 | 2022-08-01 | 632 | $3.91 | $2.5K | 231,311 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-07-28 | 2022-08-01 | 632 | $3.91 | $2.5K | 145,856 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-06-17 | 2022-06-21 | 3,440 | $3.29 | $11.3K | 231,943 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-06-17 | 2022-06-21 | 1,565 | $3.29 | $5.1K | 146,488 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-06-15 | 2022-06-17 | 6,818 | $3.24 | $22.1K | 235,383 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-06-15 | 2022-06-17 | 6,818 | $3.24 | $22.1K | 148,053 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2022-06-15 | 2022-06-17 | 1,832 | $3.24 | $5.9K | 73,885 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-06-02 | 2022-06-06 | 421 | $3.59 | $1.5K | 154,871 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-06-02 | 2022-06-06 | 4,187 | $3.59 | $15.0K | 242,201 | SEC↗ |
| LUDLUM KEN | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| Colowick Alan | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| EASTHAM KARIN | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award deriv | 2022-05-17 | 2022-05-19 | 15,035 | — | $0 | 15,035 | SEC↗ |
| LUDLUM KEN | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 43,506 | SEC↗ |
| Colowick Alan | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 13,506 | SEC↗ |
| BOWMAN A BLAINE | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 13,506 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 13,506 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 16,116 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award | 2022-05-17 | 2022-05-19 | 10,770 | — | $0 | 21,015 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-05-16 | 2022-05-18 | 1,286 | $4.86 | $6.2K | 155,830 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2022-05-16 | 2022-05-18 | 664 | $4.86 | $3.2K | 75,717 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2022-05-16 | 2022-05-18 | 2,408 | $4.86 | $11.7K | 382,444 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-05-16 | 2022-05-18 | 1,286 | $4.86 | $6.2K | 246,388 | SEC↗ |
| Moore Stephen Michael | General Counsel | S Sale | 2022-05-02 | 2022-05-04 | 5,733 | $5.53 | $31.7K | 76,381 | SEC↗ |
| Chen Richard | Chief Medical Officer | A Award | 2022-04-29 | 2022-05-18 | 1,558 | $4.76 | $7.4K | 157,116 | SEC↗ |
| West John Stephen | President and CEO | M Exercise deriv | 2022-04-20 | 2022-04-22 | 45,061 | — | $0 | 0 | SEC↗ |
| West John Stephen | President and CEO | M Exercise | 2022-04-20 | 2022-04-22 | 45,061 | $1.84 | $82.9K | 384,852 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-04-13 | 2022-04-15 | 64,430 | — | $0 | 0 | SEC↗ |
| West John Stephen | President and CEO | M Exercise | 2022-04-13 | 2022-04-15 | 64,430 | $1.84 | $118.6K | 404,221 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2022-04-13 | 2022-04-15 | 64,430 | — | $0 | 339,791 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-03-17 | 2022-03-21 | 54,347 | — | $0 | 0 | SEC↗ |
| Chen Richard | Chief Medical Officer | D To issuer | 2022-03-17 | 2022-03-21 | 1,776 | $7.98 | $14.2K | 155,558 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | D To issuer | 2022-03-17 | 2022-03-21 | 3,767 | $7.98 | $30.1K | 247,674 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-03-17 | 2022-03-21 | 54,347 | $1.84 | $100.0K | 339,804 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-03-15 | 2022-03-16 | 68,162 | — | $0 | 54,346 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-03-15 | 2022-03-16 | 68,162 | $1.84 | $125.4K | 353,619 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-15 | 2022-03-16 | 68,162 | $7.47 | $509.2K | 285,457 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-03-14 | 2022-03-16 | 21,206 | — | $0 | 122,508 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-14 | 2022-03-16 | 21,206 | $8.15 | $172.8K | 285,457 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-03-14 | 2022-03-16 | 21,206 | $1.84 | $39.0K | 306,663 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-03-11 | 2022-03-14 | 10,888 | — | $0 | 143,714 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-11 | 2022-03-14 | 10,888 | $8.99 | $97.9K | 241,672 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-11 | 2022-03-16 | 10,888 | $8.99 | $97.9K | 285,457 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-03-11 | 2022-03-16 | 10,888 | $1.84 | $20.0K | 296,339 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2022-03-10 | 2022-03-14 | 32,897 | — | $0 | 154,602 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-10 | 2022-03-14 | 32,897 | $9.38 | $308.6K | 252,560 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2022-03-10 | 2022-03-16 | 32,897 | $9.38 | $308.6K | 285,457 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2022-03-10 | 2022-03-16 | 32,897 | $1.84 | $60.5K | 318,354 | SEC↗ |
| Nieh Peter | Other | P Buy | 2022-03-03 | 2022-03-04 | 261,011 | $9.83 | $2.57M | 2,084,240 | SEC↗ |
| Nieh Peter | Other | P Buy | 2022-03-03 | 2022-03-04 | 4,750 | $10.38 | $49.3K | 4,750 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-03-02 | 2022-03-04 | 4,511 | $10.18 | $45.9K | 251,441 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-03-02 | 2022-03-04 | 471 | $10.18 | $4.8K | 157,334 | SEC↗ |
| Nieh Peter | Other | P Buy | 2022-03-02 | 2022-03-04 | 48,989 | $9.96 | $487.9K | 1,823,229 | SEC↗ |
| Bloom Olivia Kyusuk | Director | A Award | 2022-03-01 | 2022-03-02 | 10,245 | — | $0 | 10,245 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2022-01-28 | 2022-02-01 | 705 | $9.93 | $7.0K | 255,952 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2022-01-28 | 2022-02-01 | 705 | $9.93 | $7.0K | 157,805 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2022-01-19 | 2022-01-19 | 64,503 | $11.01 | $710.2K | 285,457 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2022-01-18 | 2022-01-19 | 35,484 | $11.73 | $416.2K | 349,960 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-12-17 | 2021-12-20 | 2,732 | $12.80 | $35.0K | 385,444 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2021-12-17 | 2021-12-20 | 1,563 | $12.80 | $20.0K | 158,510 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-12-17 | 2021-12-20 | 3,437 | $12.80 | $44.0K | 256,657 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-12-16 | 2021-12-17 | 97,268 | $13.42 | $1.31M | 388,176 | SEC↗ |
| Chen Richard | Chief Medical Officer | A Award | 2021-12-14 | 2021-12-16 | 80,000 | — | $0 | 160,073 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | A Award | 2021-12-14 | 2021-12-16 | 80,000 | — | $0 | 260,094 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-12-02 | 2021-12-06 | 4,184 | $12.92 | $54.1K | 180,094 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2021-12-02 | 2021-12-06 | 419 | $12.92 | $5.4K | 80,073 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-11-30 | 2021-12-02 | 100,000 | $13.65 | $1.36M | 485,444 | SEC↗ |
| Chen Richard | Chief Medical Officer | S Sale | 2021-11-17 | 2021-11-19 | 1,253 | $17.04 | $21.4K | 79,781 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-11-17 | 2021-11-19 | 1,253 | $17.04 | $21.4K | 184,278 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-11-17 | 2021-11-19 | 2,348 | $17.04 | $40.0K | 585,444 | SEC↗ |
| Chen Richard | Chief Medical Officer | A Award | 2021-10-29 | 2021-11-19 | 711 | $16.68 | $11.9K | 80,492 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-10-12 | 2021-10-14 | 100,000 | $19.33 | $1.93M | 587,792 | SEC↗ |
| Chen Richard | Chief Scientific Officer | S Sale | 2021-09-17 | 2021-09-21 | 1,088 | $21.25 | $23.1K | 81,034 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-21 | 3,152 | $21.25 | $67.0K | 185,531 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2021-09-14 | 2021-09-16 | 6,600 | $22.28 | $147.0K | 687,792 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2021-09-14 | 2021-09-16 | 93,400 | $21.65 | $2.02M | 694,392 | SEC↗ |
| Chen Richard | Chief Scientific Officer | S Sale | 2021-09-02 | 2021-09-07 | 291 | $21.92 | $6.4K | 82,122 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-09-02 | 2021-09-07 | 3,820 | $21.92 | $83.7K | 188,683 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2021-08-26 | 2021-08-30 | 77,272 | — | $0 | 0 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-08-26 | 2021-08-30 | 77,272 | $0.44 | $34.0K | 787,792 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2021-08-19 | 2021-08-23 | 115,228 | — | $0 | 77,271 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-08-19 | 2021-08-23 | 115,228 | $0.44 | $50.7K | 825,748 | SEC↗ |
| West John Stephen | President and CEO | D To issuer | 2021-08-19 | 2021-08-23 | 115,228 | $16.81 | $1.94M | 710,520 | SEC↗ |
| Chen Richard | Chief Scientific Officer | M Exercise deriv | 2021-08-06 | 2021-08-10 | 9,618 | — | $0 | 44,728 | SEC↗ |
| Chen Richard | Chief Scientific Officer | M Exercise deriv | 2021-08-06 | 2021-08-10 | 5,946 | — | $0 | 0 | SEC↗ |
| Chen Richard | Chief Scientific Officer | S Sale | 2021-08-06 | 2021-08-10 | 4,436 | $21.22 | $94.1K | 82,413 | SEC↗ |
| Chen Richard | Chief Scientific Officer | M Exercise | 2021-08-06 | 2021-08-10 | 15,564 | $21.18 | $329.6K | 86,849 | SEC↗ |
| Chen Richard | Chief Scientific Officer | M Exercise | 2021-08-06 | 2021-08-10 | 15,564 | — | $0 | 102,413 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | A Award deriv | 2021-07-27 | 2021-07-29 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Chen Richard | Chief Scientific Officer | A Award deriv | 2021-07-27 | 2021-07-29 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | A Award | 2021-07-27 | 2021-07-29 | 10,000 | — | $0 | 192,503 | SEC↗ |
| Chen Richard | Chief Scientific Officer | A Award | 2021-07-27 | 2021-07-29 | 10,000 | — | $0 | 84,980 | SEC↗ |
| West John Stephen | President and CEO | D To issuer deriv | 2021-07-15 | 2021-07-20 | 75,000 | — | $0 | 192,499 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-07-15 | 2021-07-20 | 75,000 | $0.44 | $33.0K | 710,520 | SEC↗ |
| West John Stephen | President and CEO | M Exercise deriv | 2021-07-08 | 2021-07-12 | 110,000 | — | $0 | 267,499 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-07-08 | 2021-07-12 | 110,000 | $0.44 | $48.4K | 745,520 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-07-08 | 2021-07-12 | 110,000 | $22.54 | $2.48M | 635,520 | SEC↗ |
| Chen Richard | Chief Scientific Officer | S Sale | 2021-06-17 | 2021-06-22 | 1,101 | $22.75 | $25.0K | 74,980 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-06-17 | 2021-06-22 | 2,421 | $22.75 | $55.1K | 182,503 | SEC↗ |
| West John Stephen | President and CEO | M Exercise deriv | 2021-06-15 | 2021-06-17 | 75,000 | — | $0 | 377,499 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-06-15 | 2021-06-17 | 75,000 | $0.44 | $33.0K | 635,520 | SEC↗ |
| West John Stephen | President and CEO | M Exercise deriv | 2021-06-08 | 2021-06-10 | 110,000 | — | $0 | 452,499 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-06-08 | 2021-06-10 | 100,050 | $22.38 | $2.24M | 570,470 | SEC↗ |
| West John Stephen | President and CEO | A Award | 2021-06-08 | 2021-06-10 | 110,000 | $0.44 | $48.4K | 670,520 | SEC↗ |
| West John Stephen | President and CEO | S Sale | 2021-06-08 | 2021-06-10 | 9,950 | $22.93 | $228.2K | 560,520 | SEC↗ |
| Chen Richard | Chief Scientific Officer | S Sale | 2021-06-02 | 2021-06-04 | 291 | $21.57 | $6.3K | 76,081 | SEC↗ |
| Tachibana Aaron | Chief Financial Officer | S Sale | 2021-06-02 | 2021-06-04 | 2,899 | $21.57 | $62.5K | 184,924 | SEC↗ |
| West John Stephen | President and CEO | A Award deriv | 2021-05-15 | 2021-05-18 | 107,500 | — | $0 | 107,500 | SEC↗ |